TFEB Activator 1: Mechanism, In Vivo Effects, and Potential for Neurodegenerative Disease Treatment
Exploring the power of an orally effective, mTOR-independent TFEB activator for research.
Get a Quote & SampleProduct Core Value
(1E,4E)-1,5-Bis(2-Methoxyphenyl)penta-1,4-dien-3-one
This compound is a novel curcumin analog that functions as an orally effective, mTOR-independent activator of TFEB. It is instrumental in promoting the nuclear translocation of TFEB, thereby enhancing cellular processes like autophagy. Its potential application in treating neurodegenerative diseases makes it a significant area of research interest.
- Mechanism of Action: TFEB activator 1 directly binds to TFEB, facilitating its entry into the nucleus, which is crucial for its function. This process is independent of TFEB phosphorylation and does not affect mTOR or MAPK pathway activities.
- In Vitro Efficacy: In N2a cells, TFEB activator 1 (1 μM; for 12 h) significantly increases the levels of LC3B-II, a marker for autophagy, in a dose-dependent manner.
- In Vivo Studies: Oral administration in Sprague-Dawley rats demonstrated that TFEB activator 1 dose-dependently increases LC3B-II and TFEB expression in brain tissues, indicating its therapeutic potential.
- Therapeutic Potential: With its ability to enhance autophagy and activate TFEB, this compound holds promise for the prevention or treatment of neurodegenerative diseases.
Key Advantages
Enhanced Autophagy
Discover how TFEB activator 1 enhances autophagy without inhibiting the mTOR pathway, a critical mechanism for cellular health and disease management.
TFEB Activation
Learn about the precise mechanism of TFEB activation, promoting nuclear translocation and downstream effects for cellular regulation and potential disease intervention.
Neurodegenerative Disease Focus
Explore the potential of this compound in the research and development of treatments for neurodegenerative conditions through effective TFEB activation.
Key Applications
Neurodegenerative Disease Research
Investigate the use of TFEB activator 1 for its potential in developing therapies for conditions like Alzheimer's and Parkinson's disease.
Autophagy Modulation
Utilize this compound to study and modulate the autophagy pathway, a key cellular process implicated in various physiological and pathological states.
Cellular Signaling Studies
Employ TFEB activator 1 to explore the intricacies of cellular signaling, particularly the role of TFEB in gene expression and cellular homeostasis.
Drug Discovery & Development
Leverage this research chemical in preclinical studies for drug discovery, focusing on targets related to TFEB activation and autophagy.